atovaquone has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, J; Sundquist, J; Sundquist, K; Zhang, N | 1 |
| Guo, P; Li, J; Liu, B; Liu, W; Yao, P; Zhao, G; Zheng, X | 1 |
2 other study(ies) available for atovaquone and Colorectal Neoplasms
| Article | Year |
|---|---|
Proguanil and atovaquone use is associated with lower colorectal cancer risk: a nationwide cohort study.
Topics: Adult; Antimalarials; Atovaquone; Cohort Studies; Colorectal Neoplasms; Drug Combinations; Humans; Malaria, Falciparum; Proguanil | 2022 |
Atovaquone inhibits colorectal cancer metastasis by regulating PDGFRβ/NF-κB signaling pathway.
Topics: Animals; Atovaquone; Cell Line, Tumor; Cell Movement; Colorectal Neoplasms; Epithelial-Mesenchymal Transition; Humans; NF-kappa B; Signal Transduction | 2023 |